E-LIB Suche - Ergebnisse für: Renaud, Cedric O.

1

Thyroid Disorders in Patients Treated with Dimethyl Fumarat..:

Renaud, Cédric O. ; Ziros, Panos G. ; Mathias, Amandine..
Antioxidants. 11 (2022) 5 - p. 1015 , 2022

2

Rare and common genetic variations in the Keap1/Nrf2 antiox..:

Matana, Antonela ; Ziros, Panos G. ; Chartoumpekis, Dionysios V....
Biochemical Pharmacology. 173 (2020) - p. 113605 , 2020

Link: https://doi.org/10.1016/..

3

The Keap1/Nrf2 Signaling Pathway in the Thyroid—2020 Update:

Thanas, Christina ; Ziros, Panos G. ; Chartoumpekis, Dionysios V...
Antioxidants. 9 (2020) 11 - p. 1082 , 2020

Link: https://doi.org/10.3390/..

4

Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiolo..:

Renaud, Cedric O. ; Ziros, Panos G. ; Chartoumpekis, Dionysios V...
Frontiers in Endocrinology. 10 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

5

Thyroid Disorders in Patients Treated with Dimethyl Fumarat..:

Renaud, Cédric O ; Ziros, Panos G ; Mathias, Amandine..
info:eu-repo/grantAgreement/SNSF/Careers;Academic and research careers (non-professorial);MD-PhD fellowships - MD-PhD fellowships (funded by SNSF)/323530_199386/. , 2022

Link: https://zenodo.org/recor..

6

Mice Hypomorphic for Keap1, a Negative Regulator of the Nrf..:

Ziros, Panos G ; Renaud, Cédric O ; Chartoumpekis, Dionysios V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840308/. , 2021

Link: http://www.ncbi.nlm.nih...

7

Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiolo..:

Renaud, Cedric O ; Ziros, Panos G ; Chartoumpekis, Dionysios V..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687762/. , 2019

Link: http://www.ncbi.nlm.nih...

8

Interaction of Genetic Variations in NFE2L2 and SELENOS Mod..:

Santos, Liliana R ; Durães, Cecília ; Ziros, Panos G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760180/. , 2019

Link: http://www.ncbi.nlm.nih...

9

NFE2-Related transcription factor 2 coordinates antioxidant..:

Ziros, Panos G ; Habeos, Ioannis ; Chartoumpekis, Dionysios V...
info:eu-repo/semantics/altIdentifier/url/http://www.liebertpub.com/doi/10.1089/thy.2018.0018. ,

Link: http://hdl.handle.net/11..

10

Thyroid Disorders in Patients Treated with Dimethyl Fumarat..:

Cédric O. Renaud ; Panos G. Ziros ; Amandine Mathias..
https://dx.doi.org/10.3390/antiox11051015. , 2022

Link: https://doi.org/10.3390/..

11

Thyroid Disorders in Patients Treated with Dimethyl Fumarat..:

Cédric O. Renaud ; Panos G. Ziros ; Amandine Mathias..
https://www.mdpi.com/2076-3921/11/5/1015. , 2022

Link: https://doi.org/10.3390/..

12

The Keap1/Nrf2 Signaling Pathway in the Thyroid—2020 Update:

Christina Thanas ; Panos G. Ziros ; Dionysios V. Chartoumpekis..
https://dx.doi.org/10.3390/antiox9111082. , 2020

Link: https://doi.org/10.3390/..

13

The Keap1/Nrf2 Signaling Pathway in the Thyroid—2020 Update:

Christina Thanas ; Panos G. Ziros ; Dionysios V. Chartoumpekis..
https://www.mdpi.com/2076-3921/9/11/1082. , 2020

Link: https://doi.org/10.3390/..

14

Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiolo..:

Cedric O. Renaud ; Panos G. Ziros ; Dionysios V. Chartoumpekis..
https://www.frontiersin.org/article/10.3389/fendo.2019.00510/full. , 2019

Link: https://doi.org/10.3389/..

15

Quantification of Detergents Complexed with Membrane Protei..:

Chaptal, V. (Vincent) ; Delolme, F. (Frédéric) ; Kilburg, A. (Arnaud)... , 2017

Link: http://www.nature.com/ar..